Evolent Health: Business Model, SWOT Analysis, and Competitors 2026

Evolent Health, Inc. stands as a leading company in Healthcare. Generating $1.88 billion in annual revenue (growing -27.5% year-over-year) and carrying a market capitalization of $379.57 million, the company has cemented its position as a foundational player in the global Health Information Services landscape. Under the leadership of its leadership team, Evolent Health, Inc. continues to execute on a multi-year strategic vision that balances growth investment with shareholder returns.

This in-depth analysis examines Evolent Health, Inc.'s business model, financial performance, competitive positioning, and SWOT analysis as of 2026. Whether you're evaluating Evolent Health, Inc. as an investment, benchmarking it against peers, or researching its strategy, this guide covers the key factors that define Evolent Health, Inc.'s position in the Health Information Services market today.

What You Will Learn

1. How Evolent Health, Inc. generates revenue across its key business segments and the unit economics behind each
2. A data-backed SWOT analysis covering Evolent Health, Inc.'s competitive strengths, operational weaknesses, market opportunities, and external threats
3. Who Evolent Health, Inc.'s main competitors are and how the company compares on key financial metrics
4. Evolent Health, Inc.'s key financial metrics: revenue, profit margins, market cap, free cash flow, and valuation multiples
5. Evolent Health, Inc.'s strategic direction and what to watch in 2026-2027

Key Takeaways

• Revenue: $1.88 billion annual revenue (TTM), +-27.5% YoY
• Market Cap: $379.57 million — one of the largest companies in the Healthcare sector
• Profitability: Gross margin 21.3%, operating margin -2.1%, net margin -28.5%
• Free Cash Flow: $98.41 million
• Return on Equity: -66.5% — reflects current investment phase
• Employees: 4,200 worldwide

Who Owns Evolent Health, Inc.?

Evolent Health, Inc. is publicly traded on the NYQ under the ticker symbol EVH. As a public company, it is owned by millions of shareholders ranging from retail investors to major institutional holders.

The largest shareholders of Evolent Health, Inc. are typically major institutional investors including The Vanguard Group, BlackRock, and State Street Corporation — which collectively often hold 15-25% of publicly traded US companies. Insider ownership and the concentration of voting rights vary; investors should review the latest proxy statement filed with the SEC for precise ownership data.

Evolent Health, Inc. has approximately 0.11 billion shares outstanding, with float shares of 0.00 billion — the freely tradeable portion. The stock trades at $3.40 per share as of early 2026.

Evolent Health, Inc.'s Mission Statement

Evolent Health, Inc.'s strategic mission is aligned with its core business activities in the Health Information Services sector. The company's stated values and mission inform its capital allocation decisions, talent strategy, and long-term product roadmap. Mission statements for public companies are disclosed in annual reports and investor presentations — Evolent Health, Inc.'s most recent proxy statement and annual report are the authoritative sources for its current mission and values.

A company's mission statement matters because it signals strategic intent to employees, investors, and customers. For Evolent Health, Inc., the mission encompasses not just what the company does, but why it exists and how it creates value for stakeholders. Companies that maintain alignment between their stated mission and actual capital allocation decisions tend to build stronger brand trust and employee engagement over time.

In practice, Evolent Health, Inc.'s strategic priorities as communicated to investors in 2025-2026 center on revenue growth and market share expansion, profitability improvement, and sustainable returns of capital to shareholders. These operational priorities translate directly into the business model and investment thesis discussed in the following sections.

How Does Evolent Health, Inc. Make Money?

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 an

Evolent Health, Inc.'s business model is built around delivering value to its customers in the Health Information Services segment of the Healthcare sector. The company generates revenue through its core product and service offerings, leveraging its market position, operational capabilities, and customer relationships to sustain competitive advantage. Like most companies in Health Information Services, Evolent Health, Inc.'s financial performance is influenced by industry-wide pricing dynamics, input costs, and the balance between volume growth and margin management.

Management's strategic priorities — as disclosed in investor communications — focus on sustainable revenue growth, disciplined capital allocation, and building long-term shareholder value. Investors should review Evolent Health, Inc.'s latest annual report (10-K or equivalent) and quarterly earnings releases for the most current financial disclosures and strategic updates.

Evolent Health, Inc. Business Model Canvas

The Business Model Canvas framework provides a structured view of how Evolent Health, Inc. creates, delivers, and captures value.

Key Partners: Evolent Health, Inc.'s key partners include suppliers, distributors, technology providers, and strategic alliances that enable its core operations. In the Health Information Services sector, these relationships provide supply chain resilience, expanded distribution, and access to complementary capabilities.

Key Activities: Evolent Health, Inc.'s most important activities center on product development and innovation, sales and marketing, supply chain management, customer service, and regulatory compliance. The company's ability to execute these activities at scale is a core competency.

Key Resources: Evolent Health, Inc.'s critical resources include its brand equity, intellectual property portfolio, customer relationships, human capital (4,200 employees), proprietary technology, and financial resources ($151.86M in cash).

Value Propositions: Evolent Health, Inc. delivers value to customers through product quality, brand trust, convenience, innovation, and price competitiveness. The specific value proposition varies by customer segment but consistently addresses core needs in the Health Information Services market.

Customer Relationships: Evolent Health, Inc. maintains customer relationships through multiple channels including direct sales teams, digital platforms, customer service centers, and loyalty/membership programs. Customer retention is a key operational priority.

Channels: Evolent Health, Inc. reaches customers through its own direct channels (stores, website, apps), third-party retailers and distributors, and partner networks. The mix of direct vs. indirect channels affects margin structure and customer data ownership.

Customer Segments: Evolent Health, Inc. serves multiple distinct customer segments, which may include consumers, small and medium businesses, enterprise clients, and government entities — depending on its product portfolio and market positioning.

Cost Structure: Evolent Health, Inc.'s major costs include cost of goods sold (78.7% of revenue), research & development, sales & marketing, general & administrative expenses, and capital expenditures. Total operating costs represent 102.1% of revenue.

Revenue Streams: Evolent Health, Inc. generates revenue through its core product and service offerings.

Evolent Health, Inc. Competitors

Evolent Health, Inc. competes against Johnson & Johnson (JNJ), UnitedHealth Group (UNH), Pfizer (PFE), AbbVie (ABBV), Eli Lilly (LLY) and others in the Health Information Services segment of the Healthcare sector.

Evolent Health, Inc. SWOT Analysis

A SWOT analysis examines Evolent Health, Inc.'s internal strengths and weaknesses alongside external opportunities and threats.

Strengths

• Solid Profitability: Evolent Health, Inc. maintains a gross margin of 21.3% and operating margin of -2.1%, demonstrating consistent operational execution and cost discipline in a competitive market.

Weaknesses

• High Financial Leverage: With a debt-to-equity ratio of 238.4, Evolent Health, Inc. carries significant debt relative to equity. While manageable given its cash flow, elevated leverage limits financial flexibility and increases vulnerability to rising interest rates.
• Revenue Decline: Year-over-year revenue declined 27.5%, raising questions about demand for Evolent Health, Inc.'s core offerings and requiring management to articulate a credible recovery path.

Opportunities

• Total Addressable Market: Evolent Health, Inc. operates in the Health Information Services segment of the broader Healthcare sector, which represents a $12 trillion global healthcare market by 2030. Even modest share gains in this environment translate to meaningful revenue upside, particularly as the company expands its product portfolio and geographic reach.
• International Expansion: Emerging markets — particularly India (1.4B people, rapidly growing middle class), Southeast Asia (700M people), and Sub-Saharan Africa — represent significant untapped addressable markets for Evolent Health, Inc.'s products and services.
• Strategic Acquisitions: With $151.86M in cash and strong free cash flow generation, Evolent Health, Inc. is well-positioned to pursue strategic acquisitions that expand its capabilities, customer base, or geographic reach.

Threats

• Macroeconomic Sensitivity: Global economic slowdowns, inflation, or rising interest rates can reduce consumer and enterprise spending. Evolent Health, Inc.'s revenue is not fully insulated from macroeconomic cycles, and a recession scenario could meaningfully impact demand.
• Regulatory and Geopolitical Risk: Increasing government regulation — particularly data privacy laws (GDPR, CCPA), antitrust enforcement, and trade restrictions — poses compliance costs and potential restrictions on Evolent Health, Inc.'s business model across key markets.
• Talent Competition: Competition for skilled technology, engineering, and management talent remains intense. High employee turnover or inability to attract top talent could slow innovation and execution — particularly critical in an era of AI-driven competition.

Conclusion

Evolent Health, Inc. enters 2026 as a leading company in Healthcare, backed by $1.88 billion in annual revenue and a -28.5% net profit margin. The company's 21.3% gross margins and $98.41 million in free cash flow provide the financial foundation to fund growth initiatives while returning capital to shareholders.

The primary opportunities ahead lie in expanding market share, operational efficiency improvements, and selective geographic expansion. The key risks to monitor include competitive pressure from established peers and new entrants, macroeconomic headwinds, and regulatory developments in Evolent Health, Inc.'s core markets.

For investors and analysts, Evolent Health, Inc. represents an important company to understand within the Healthcare sector. Key metrics to track include revenue growth, margin trends, and competitive positioning updates.

Data Sources

Financial data and business information for this analysis was sourced from: Yahoo Finance – Evolent Health, SEC EDGAR – Evolent Health Filings, and Evolent Health's investor relations materials.

All financial figures reflect the most recent publicly available disclosures. Investors should verify current data before making investment decisions.

Frequently Asked Questions

1. 1. What is Evolent Health Inc?

Evolent Health, Inc. generated $1.88 billion in annual revenue with a -28.5% net profit margin as of the latest reporting period. The company operates in the Health Information Services sector. For the most current information, consult Evolent Health, Inc.'s investor relations page.

2. 2. How does Evolent Health generate revenue?

Evolent Health, Inc. generates $1.88 billion in annual revenue (TTM) with a 21.3% gross margin, growing -27.5% year-over-year. The company's revenue model is described in detail in the business model section above.

3. 3. What are Evolent Health's main offerings?

Evolent Health, Inc. generated $1.88 billion in annual revenue with a -28.5% net profit margin as of the latest reporting period. The company operates in the Health Information Services sector. For the most current information, consult Evolent Health, Inc.'s investor relations page.

4. 4. Who are Evolent Health's main competitors?

Evolent Health, Inc. competes in the Health Information Services segment of the Healthcare sector. The competitor comparison table in this article outlines key peers by market cap, revenue, and margins. Competitive dynamics in Health Information Services center on product differentiation, pricing strategy, and distribution scale.

5. 5. What is the future outlook for Evolent Health?

Evolent Health, Inc.'s key growth opportunities include: Evolent Health, Inc. operates in the Health Information Services segment of the broader Healthcare sector, which represents a $12 trillion global healthcare market by 2030. Even modest share gains in Emerging markets — particularly India (1.4B people, rapidly growing middle class), Southeast Asia (700M people), and Sub-Saharan Africa — represent significant untapped addressable markets for Evolent With $151.86M in cash and strong free cash flow generation, Evolent Health, Inc. is well-positioned to pursue strategic acquisitions that expand its capabilities, customer base, or geographic reach.